dc.contributor.author | Eriksson, Mia D. | |
dc.contributor.author | Eriksson, Johan G. | |
dc.contributor.author | Korhonen, Päivi | |
dc.contributor.author | Koponen, Hannu | |
dc.contributor.author | Salonen, Minna K. | |
dc.contributor.author | Mikkola, Tuija M. | |
dc.contributor.author | Kajantie, Eero | |
dc.contributor.author | Wasenius, Niko S. | |
dc.contributor.author | von Bonsdorff, Mikaela | |
dc.contributor.author | Kautiainen, Hannu | |
dc.contributor.author | Laine, Merja K. | |
dc.date.accessioned | 2022-11-09T06:10:53Z | |
dc.date.available | 2022-11-09T06:10:53Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Eriksson, M. D., Eriksson, J. G., Korhonen, P., Koponen, H., Salonen, M. K., Mikkola, T. M., Kajantie, E., Wasenius, N. S., von Bonsdorff, M., Kautiainen, H., & Laine, M. K. (2023). Depressive Symptoms and Mortality : Findings from Helsinki Birth Cohort Study. <i>Acta psychiatrica scandinavica</i>, <i>147</i>(2), 175-185. <a href="https://doi.org/10.1111/acps.13512" target="_blank">https://doi.org/10.1111/acps.13512</a> | |
dc.identifier.other | CONVID_159378036 | |
dc.identifier.uri | https://jyx.jyu.fi/handle/123456789/83824 | |
dc.description.abstract | Background
Individuals with depression and depressive symptoms have a higher mortality rate than non-depressed individuals. The increased comorbidity and mortality associated with depression has remained largely unexplained. The underlying pathophysiological differences between depressive subtypes, melancholic and non-melancholic, may provide some explanation to this phenomenon.
Methods
1995 participants (mean age 61 years) from the Helsinki Birth Cohort Study were recruited for this prospective study and followed up for a mean of 14.1 years. Information regarding medical history, lifestyle, and biochemical parameters were obtained. Depressive symptoms were assessed using the Beck Depression Inventory. Standardized mortality ratios were calculated.
Results
Participants were followed up for a total of 28 044 person-years. The melancholic depressive group had an increased adjusted risk of mortality [HR 1.49 (95% CI: 1.02-2.20)] when compared to the non-depressive group. Comparing mortality to the whole population of Finland using standardized mortality ratios (SMR) both the non-melancholic [1.11 (95% CI: 0.85-1.44)] and melancholic depressive [1.26 (95% CI: 0.87-1.81)] groups had higher mortality than the non-depressive group [ 0.82 (95% CI: 0.73-0.93)].
Conclusions
Melancholic depressive symptoms are most strongly related to a higher mortality risk. | en |
dc.format.mimetype | application/pdf | |
dc.language.iso | eng | |
dc.publisher | Wiley-Blackwell | |
dc.relation.ispartofseries | Acta psychiatrica scandinavica | |
dc.rights | CC BY 4.0 | |
dc.title | Depressive Symptoms and Mortality : Findings from Helsinki Birth Cohort Study | |
dc.type | article | |
dc.identifier.urn | URN:NBN:fi:jyu-202211095125 | |
dc.contributor.laitos | Liikuntatieteellinen tiedekunta | fi |
dc.contributor.laitos | Faculty of Sport and Health Sciences | en |
dc.contributor.oppiaine | Gerontologia ja kansanterveys | fi |
dc.contributor.oppiaine | Gerontology and Public Health | en |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | |
dc.type.coar | http://purl.org/coar/resource_type/c_2df8fbb1 | |
dc.description.reviewstatus | peerReviewed | |
dc.format.pagerange | 175-185 | |
dc.relation.issn | 0001-690X | |
dc.relation.numberinseries | 2 | |
dc.relation.volume | 147 | |
dc.type.version | publishedVersion | |
dc.rights.copyright | © 2022 The Authors. Acta Psychiatrica Scandinavica published by John Wiley & Sons Ltd. | |
dc.rights.accesslevel | openAccess | fi |
dc.subject.yso | stressi | |
dc.subject.yso | kuolleisuus | |
dc.subject.yso | mielenterveysongelmat | |
dc.subject.yso | masennus | |
dc.subject.yso | elintavat | |
dc.subject.yso | mielenterveys | |
dc.subject.yso | terveys | |
dc.subject.yso | mielenterveyshäiriöt | |
dc.subject.yso | elämäntapa | |
dc.subject.yso | ikääntyminen | |
dc.format.content | fulltext | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p133 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p5003 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p20629 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p7995 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p5530 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p1949 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p2762 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p990 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p8760 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p5056 | |
dc.rights.url | https://creativecommons.org/licenses/by/4.0/ | |
dc.relation.doi | 10.1111/acps.13512 | |
jyx.fundinginformation | The HBCS has been supported by grants from Finska Läkaresällskapet, the Finnish Special Governmental Subsidy for Health Sciences, Academy of Finland (126775, 127437, 129255, 129306, 129907, 130326, 134791, 209072, 210595, 213225, 263924, 275074 and 315690), Samfundet Folkhälsan, Liv och Hälsa, EU FP7 [Developmental Origins of Healthy Aging (DORIAN)] project number 278603, and EU H2020-PHC-2014-DynaHealth grant 633595 and EU Horizon 2020 Award 733206 LIFECYCLE (all for the Helsinki Birth Cohort Study), European Commission, Horizon2020 award 733280 RECAP, Foundation for Cardiovascular Research, Foundation for Diabetes Research, Foundation for Pediatric Research, Novo Nordisk Foundation, Signe and Ane Gyllenberg Foundation. | |
dc.type.okm | A1 | |